SORAFENIB

SORAFENIB was reported 20700 times

SORAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATOCELLULAR CARCINOMA 1899 0.2495
1 PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED 17 0.2329
2 ALPHA 1 FOETOPROTEIN INCREASED 144 0.2022
3 HEPATIC NEOPLASM MALIGNANT 391 0.1845
4 LIVER CARCINOMA RUPTURED 44 0.1746
5 RENAL CELL CARCINOMA STAGE IV 16 0.1416
6 PARATHYROID TUMOUR MALIGNANT 16 0.1250
7 TUMOUR EMBOLISM 18 0.0938
8 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2174 0.0932
9 PLANTAR ERYTHEMA 23 0.0931
10 POIKILODERMA 10 0.0926
11 TUMOUR THROMBOSIS 21 0.0921
12 ORAL LICHENOID REACTION 10 0.0917
13 THYROID CANCER METASTATIC 24 0.0854
14 DESMOID TUMOUR 15 0.0714
15 PNEUMONIA ADENOVIRAL 14 0.0707
16 HEPATIC RUPTURE 15 0.0670
17 BLOOD AMYLASE INCREASED 114 0.0665
18 PALMOPLANTAR KERATODERMA 47 0.0648
19 TUMOUR RUPTURE 36 0.0641
20 RENAL CELL CARCINOMA STAGE UNSPECIFIED 35 0.0616
21 ADENOVIRAL HEPATITIS 14 0.0596
22 METASTATIC RENAL CELL CARCINOMA 104 0.0568
23 ACUTE MYELOID LEUKAEMIA RECURRENT 121 0.0563
24 RENAL CELL CARCINOMA 274 0.0560
25 METASTASES TO ADRENALS 51 0.0553
26 FOOD REFUSAL 46 0.0526
27 COMA HEPATIC 37 0.0499
28 HEPATIC ENCEPHALOPATHY 455 0.0487
29 THERAPEUTIC EMBOLISATION 14 0.0449
30 HYPERKERATOSIS 246 0.0445
31 SCROTAL ULCER 11 0.0421
32 ABDOMINAL CAVITY DRAINAGE 16 0.0379
33 OESOPHAGEAL VARICES HAEMORRHAGE 82 0.0377
34 HEPATIC CANCER METASTATIC 32 0.0374
35 GASTRIC VARICES HAEMORRHAGE 12 0.0366
36 KERATOACANTHOMA 25 0.0365
37 METASTASES TO PANCREAS 16 0.0361
38 HEPATIC CANCER RECURRENT 10 0.0352
39 VARICOSE VEIN RUPTURED 11 0.0343
40 METASTASES TO LUNG 395 0.0342
41 HAEMOBILIA 14 0.0337
42 HEPATECTOMY 10 0.0319
43 HYPERAMYLASAEMIA 17 0.0312
44 OSTEOSARCOMA 12 0.0312
45 TUMOUR NECROSIS 32 0.0303
46 AMMONIA INCREASED 146 0.0286
47 METASTASES TO ABDOMINAL CAVITY 14 0.0285
48 HEPATORENAL SYNDROME 48 0.0284
49 GASTRIC ANTRAL VASCULAR ECTASIA 15 0.0284
50 METASTASES TO KIDNEY 15 0.0272
51 ALBUMIN URINE PRESENT 10 0.0263
52 SKIN TOXICITY 148 0.0262
53 APHAGIA 117 0.0243
54 METASTASES TO SPLEEN 10 0.0242
55 BLEEDING VARICOSE VEIN 13 0.0240
56 PORTAL HYPERTENSIVE GASTROPATHY 13 0.0230
57 GRAFT VERSUS HOST DISEASE IN LUNG 11 0.0230
58 TUMOUR INVASION 11 0.0226
59 PANCREATIC ENZYMES INCREASED 33 0.0225
60 HEPATOBILIARY DISEASE 14 0.0224
61 METASTASES TO PERITONEUM 55 0.0218
62 HYPOTRICHOSIS 14 0.0217
63 ASCITES 633 0.0215
64 HEPATIC HAEMORRHAGE 18 0.0210
65 GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
66 RENAL CANCER METASTATIC 16 0.0208
67 PORTAL VEIN THROMBOSIS 67 0.0207
68 MORPHOEA 10 0.0207
69 SKIN WOUND 34 0.0200
70 RETROPERITONEAL LYMPHADENOPATHY 10 0.0190
71 LIPASE INCREASED 141 0.0184
72 HEPATIC FUNCTION ABNORMAL 668 0.0179
73 TUMOUR HAEMORRHAGE 51 0.0179
74 TUMOUR PAIN 23 0.0175
75 HYPOPHOSPHATAEMIA 128 0.0173
76 HEPATIC FAILURE 509 0.0169
77 HYDROTHORAX 13 0.0157
78 SKIN HYPERTROPHY 44 0.0156
79 VARICES OESOPHAGEAL 47 0.0155
80 METASTASES TO SPINE 52 0.0155
81 METASTASES TO LYMPH NODES 103 0.0152
82 ENTEROCOLITIS INFECTIOUS 14 0.0152
83 HEPATIC LESION 65 0.0150
84 ABDOMINAL LYMPHADENOPATHY 13 0.0150
85 ANAL ULCER 12 0.0147
86 CANCER PAIN 37 0.0145
87 GRAFT VERSUS HOST DISEASE IN SKIN 30 0.0136
88 OROPHARYNGEAL BLISTERING 22 0.0135
89 METASTASES TO PLEURA 14 0.0133
90 BLISTER 736 0.0131
91 TONGUE BLISTERING 29 0.0130
92 LIVER ABSCESS 41 0.0126
93 GENITAL RASH 18 0.0126
94 HEPATIC CANCER 303 0.0126
95 LYMPHADENOPATHY MEDIASTINAL 24 0.0125
96 LYMPHANGIOSIS CARCINOMATOSA 13 0.0125
97 BLOOD BILIRUBIN INCREASED 336 0.0124
98 INTRA-ABDOMINAL FLUID COLLECTION 22 0.0123
99 PALMAR ERYTHEMA 14 0.0121
100 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 15 0.0120
101 ANOREXIA 154 0.0119
102 YELLOW SKIN 55 0.0117
103 TONGUE ULCERATION 39 0.0115
104 PAPILLARY THYROID CANCER 20 0.0115
105 BLISTER INFECTED 9 0.0115
106 HEPATIC NEOPLASM 37 0.0113
107 CYTOMEGALOVIRUS INFECTION REACTIVATION 50 0.0113
108 ASTERIXIS 12 0.0113
109 ERYTHEMA MULTIFORME 104 0.0111
110 BLOOD BILIRUBIN ABNORMAL 14 0.0109
111 HYPERAMMONAEMIA 54 0.0108
112 SCROTAL SWELLING 10 0.0107
113 METASTASIS 76 0.0106
114 HEPATIC PAIN 45 0.0105
115 METASTASES TO BONE 166 0.0101
116 BLOOD ALBUMIN DECREASED 78 0.0098
117 JAUNDICE 262 0.0097
118 METASTASES TO SKIN 10 0.0097
119 MALIGNANT PLEURAL EFFUSION 16 0.0095
120 GRAFT VERSUS HOST DISEASE 68 0.0094
121 FLUID INTAKE REDUCED 47 0.0094
122 NIPPLE PAIN 19 0.0093
123 GASTROINTESTINAL PERFORATION 38 0.0091
124 HYPOALBUMINAEMIA 71 0.0091
125 GENE MUTATION 18 0.0091
126 GLOSSITIS 32 0.0090
127 OCULAR ICTERUS 39 0.0090
128 THYROID CANCER 107 0.0089
129 HEPATIC MASS 17 0.0088
130 GASTRIC ULCER PERFORATION 11 0.0087
131 GASTROINTESTINAL ULCER 19 0.0086
132 NEPHROTIC SYNDROME 58 0.0085
133 BILE DUCT OBSTRUCTION 16 0.0084
134 RASH GENERALISED 217 0.0084
135 GASTROINTESTINAL TOXICITY 40 0.0083
136 PHARYNGEAL ULCERATION 11 0.0083
137 LEUKAEMIA RECURRENT 14 0.0083
138 DIVERTICULAR PERFORATION 17 0.0083
139 AMYLASE INCREASED 30 0.0081
140 PERITONEAL HAEMORRHAGE 11 0.0079
141 DIABETIC METABOLIC DECOMPENSATION 11 0.0079
142 JAUNDICE CHOLESTATIC 28 0.0079
143 HYPERBILIRUBINAEMIA 82 0.0079
144 METASTASES TO CENTRAL NERVOUS SYSTEM 101 0.0078
145 MEDICAL PROCEDURE 13 0.0078
146 ABDOMINAL RIGIDITY 21 0.0077
147 BONE MARROW FAILURE 155 0.0076
148 BONE MARROW TOXICITY 9 0.0076
149 STOMATITIS 461 0.0076
150 OESOPHAGEAL HAEMORRHAGE 10 0.0076
151 PAIN OF SKIN 200 0.0074
152 CHOLANGITIS 46 0.0074
153 CACHEXIA 38 0.0074
154 ORAL PAIN 165 0.0074
155 DYSPHONIA 429 0.0073
156 MUCOUS MEMBRANE DISORDER 10 0.0073
157 TUMOUR MARKER INCREASED 35 0.0073
158 GASTROINTESTINAL STROMAL TUMOUR 19 0.0071
159 PNEUMONIA LEGIONELLA 11 0.0069
160 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 11 0.0069
161 BILIRUBIN CONJUGATED INCREASED 16 0.0068
162 IMPAIRED SELF-CARE 14 0.0068
163 SKIN INDURATION 14 0.0067
164 INTRA-ABDOMINAL HAEMORRHAGE 16 0.0067
165 METASTASES TO LIVER 118 0.0067
166 HYPERAESTHESIA 55 0.0067
167 PROTEINURIA 126 0.0066
168 CEREBRAL ISCHAEMIA 34 0.0066
169 ABASIA 163 0.0066
170 HYPERURICAEMIA 27 0.0066
171 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
172 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 33 0.0065
173 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0065
174 EXPOSED BONE IN JAW 14 0.0065
175 DYSENTERY 12 0.0064
176 MUCOSAL INFLAMMATION 168 0.0064
177 LARGE INTESTINE PERFORATION 44 0.0063
178 HAEMATEMESIS 160 0.0063
179 AORTIC DISSECTION 26 0.0063
180 DECREASED APPETITE 1453 0.0062
181 GLOSSODYNIA 140 0.0062
182 PERFORMANCE STATUS DECREASED 29 0.0062
183 ARTERIAL THROMBOSIS 12 0.0062
184 ENCEPHALOPATHY 151 0.0061
185 SQUAMOUS CELL CARCINOMA OF SKIN 37 0.0061
186 CHRONIC GRAFT VERSUS HOST DISEASE 22 0.0061
187 EXFOLIATIVE RASH 16 0.0061
188 HICCUPS 49 0.0060
189 GINGIVAL BLEEDING 81 0.0059
190 WOUND DEHISCENCE 20 0.0059
191 MOUTH HAEMORRHAGE 43 0.0059
192 HYPOCALCAEMIA 111 0.0059
193 PORTAL HYPERTENSION 18 0.0058
194 BLOOD LACTATE DEHYDROGENASE INCREASED 92 0.0058
195 BONE MARROW TRANSPLANT 11 0.0058
196 SKIN EXFOLIATION 488 0.0058
197 MELAENA 127 0.0058
198 BLOOD BLISTER 18 0.0058
199 SKIN LESION 158 0.0058
200 DERMATITIS ACNEIFORM 35 0.0057
201 SKIN PAPILLOMA 23 0.0057
202 CEREBRAL INFARCTION 139 0.0057
203 TUMOUR LYSIS SYNDROME 50 0.0057
204 HEPATIC CIRRHOSIS 106 0.0056
205 SKIN FISSURES 110 0.0056
206 ASPARTATE AMINOTRANSFERASE INCREASED 296 0.0056
207 SKIN REACTION 78 0.0055
208 DUODENAL ULCER 39 0.0055
209 FEEDING DISORDER 111 0.0055
210 HAEMOPTYSIS 152 0.0054
211 HYPERTENSION 1154 0.0054
212 SKIN ULCER 140 0.0054
213 PNEUMOPERITONEUM 10 0.0054
214 LARGE INTESTINAL HAEMORRHAGE 12 0.0053
215 LIVER DISORDER 237 0.0053
216 GASTRIC ULCER 101 0.0053
217 LUNG ABSCESS 11 0.0052
218 ALANINE AMINOTRANSFERASE ABNORMAL 11 0.0052
219 HAEMOTHORAX 15 0.0052
220 FAECES DISCOLOURED 112 0.0052
221 EXTREMITY NECROSIS 9 0.0052
222 ABNORMAL LOSS OF WEIGHT 35 0.0051
223 EMPYEMA 10 0.0050
224 ACTINIC KERATOSIS 13 0.0050
225 HYPOPHAGIA 128 0.0050
226 EATING DISORDER 106 0.0050
227 TONGUE DISCOMFORT 21 0.0049
228 SPINAL CORD COMPRESSION 19 0.0049
229 RETINAL VEIN OCCLUSION 14 0.0049
230 BLOOD URIC ACID INCREASED 28 0.0048
231 CAPILLARY LEAK SYNDROME 10 0.0048
232 ACUTE CORONARY SYNDROME 40 0.0048
233 ADENOVIRUS INFECTION 14 0.0048
234 SKIN WARM 28 0.0048
235 NON-SMALL CELL LUNG CANCER 23 0.0048
236 NEOPLASM 55 0.0048
237 DISSEMINATED INTRAVASCULAR COAGULATION 67 0.0048
238 OESOPHAGEAL ULCER 18 0.0047
239 DIARRHOEA 2966 0.0046
240 GENERALISED ERYTHEMA 26 0.0046
241 RASH MACULO-PAPULAR 100 0.0045
242 CANDIDIASIS 18 0.0045
243 ANAL ABSCESS 24 0.0044
244 SKIN NECROSIS 23 0.0044
245 ALANINE AMINOTRANSFERASE INCREASED 272 0.0044
246 SUSPECTED OFF LABEL USE 20 0.0044
247 GINGIVAL PAIN 35 0.0044
248 VENOOCCLUSIVE DISEASE 11 0.0044
249 PLEURAL EFFUSION 267 0.0044
250 CHANGE OF BOWEL HABIT 9 0.0044
251 HEPATITIS FULMINANT 13 0.0044
252 BLOOD PHOSPHORUS DECREASED 16 0.0044
253 ACUTE MYELOID LEUKAEMIA 68 0.0044
254 PROTHROMBIN TIME PROLONGED 26 0.0043
255 PULMONARY HAEMORRHAGE 34 0.0043
256 PLATELET COUNT DECREASED 463 0.0043
257 DERMATITIS BULLOUS 31 0.0043
258 FAILURE TO THRIVE 22 0.0042
259 LUNG NEOPLASM 18 0.0042
260 PNEUMATOSIS INTESTINALIS 12 0.0042
261 PRE-EXISTING CONDITION IMPROVED 26 0.0042
262 GASTRIC ULCER HAEMORRHAGE 23 0.0041
263 MALIGNANT NEOPLASM PROGRESSION 425 0.0041
264 ORAL INTAKE REDUCED 10 0.0041
265 ABDOMINAL ABSCESS 18 0.0041
266 SUDDEN DEATH 43 0.0041
267 BLOOD SODIUM DECREASED 76 0.0040
268 PANCYTOPENIA 224 0.0040
269 EXERCISE TOLERANCE DECREASED 23 0.0040
270 THYROIDITIS 12 0.0040
271 MULTI-ORGAN FAILURE 69 0.0040
272 HEPATIC NECROSIS 15 0.0040
273 HEPATOMEGALY 39 0.0040
274 SUBCUTANEOUS ABSCESS 19 0.0040
275 C-REACTIVE PROTEIN INCREASED 144 0.0040
276 ALOPECIA 776 0.0039
277 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
278 CHEILITIS 21 0.0039
279 BLOOD POTASSIUM INCREASED 63 0.0039
280 THERAPEUTIC PRODUCT INEFFECTIVE 15 0.0039
281 FEELING OF DESPAIR 18 0.0039
282 NEOPLASM PROGRESSION 134 0.0038
283 MUCORMYCOSIS 10 0.0038
284 MOUTH ULCERATION 81 0.0038
285 BLOOD PRESSURE INCREASED 587 0.0038
286 GAMMA-GLUTAMYLTRANSFERASE INCREASED 85 0.0038
287 DEVICE RELATED INFECTION 59 0.0038
288 HEPATITIS B 23 0.0038
289 DRY SKIN 509 0.0038
290 VOMITING PROJECTILE 11 0.0038
291 GENERAL PHYSICAL HEALTH DETERIORATION 440 0.0038
292 MUSCLE FATIGUE 16 0.0038
293 EPISTAXIS 281 0.0038
294 AZOTAEMIA 15 0.0038
295 RASH VESICULAR 18 0.0037
296 SQUAMOUS CELL CARCINOMA 35 0.0037
297 ERYTHEMA NODOSUM 13 0.0037
298 ELECTROLYTE IMBALANCE 43 0.0037
299 THROMBOCYTOPENIA 413 0.0037
300 HAEMATOTOXICITY 35 0.0037
301 GASTRIC PERFORATION 10 0.0037
302 PANCREATIC DISORDER 18 0.0036
303 ABDOMINAL PAIN 842 0.0036
304 HYPOTHYROIDISM 115 0.0036
305 DISEASE PROGRESSION 426 0.0036
306 TRANSAMINASES INCREASED 80 0.0036
307 SKIN DISORDER 120 0.0036
308 BLOOD ALKALINE PHOSPHATASE INCREASED 89 0.0036
309 PHARYNGOLARYNGEAL PAIN 19 0.0036
310 TOXIC SKIN ERUPTION 36 0.0036
311 ANAL HAEMORRHAGE 10 0.0036
312 BEDRIDDEN 46 0.0035
313 LEUKOENCEPHALOPATHY 13 0.0035
314 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
315 LYMPHADENOPATHY 123 0.0035
316 RASH MACULAR 121 0.0035
317 MONOPLEGIA 15 0.0034
318 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 21 0.0034
319 ACUTE HEPATIC FAILURE 47 0.0034
320 GASTRITIS EROSIVE 16 0.0034
321 URINE OUTPUT DECREASED 30 0.0034
322 GASTROINTESTINAL NECROSIS 10 0.0034
323 SKIN EROSION 11 0.0034
324 ORAL DISORDER 25 0.0034
325 PROTEIN URINE PRESENT 17 0.0034
326 NECROTISING FASCIITIS 12 0.0034
327 MALNUTRITION 38 0.0034
328 DEHYDRATION 453 0.0034
329 ABDOMINAL MASS 9 0.0034
330 RASH 1462 0.0034
331 BONE LESION 12 0.0033
332 MOUTH SWELLING 19 0.0033
333 WEIGHT DECREASED 919 0.0033
334 MASS 46 0.0033
335 PAIN IN EXTREMITY 966 0.0033
336 LYMPHOPENIA 46 0.0032
337 MYOCARDIAL ISCHAEMIA 37 0.0032
338 PIGMENTATION DISORDER 20 0.0032
339 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
340 ATELECTASIS 31 0.0032
341 LIVER FUNCTION TEST ABNORMAL 93 0.0032
342 DECUBITUS ULCER 26 0.0032
343 ANAL FISSURE 17 0.0032
344 ASTHENIA 1189 0.0032
345 ANAEMIA 599 0.0031
346 CARDIOTOXICITY 28 0.0031
347 FEBRILE NEUTROPENIA 207 0.0031
348 ENTEROCOLITIS 18 0.0031
349 HYPOGLYCAEMIA 151 0.0031
350 PROCTALGIA 20 0.0031
351 PYREXIA 1074 0.0031
352 HAEMORRHAGE SUBCUTANEOUS 11 0.0031
353 BILIARY COLIC 9 0.0031
354 GENERALISED OEDEMA 38 0.0031
355 OEDEMA PERIPHERAL 374 0.0031
356 WOUND SECRETION 12 0.0031
357 NAIL DISCOLOURATION 12 0.0030
358 GASTRIC HAEMORRHAGE 35 0.0030
359 FACIAL PAIN 27 0.0030
360 IMMUNODEFICIENCY 45 0.0030
361 GASTROINTESTINAL HAEMORRHAGE 252 0.0030
362 METASTATIC NEOPLASM 13 0.0030
363 BLOOD CULTURE POSITIVE 9 0.0030
364 DERMATITIS EXFOLIATIVE 15 0.0030
365 CORONARY ARTERY STENOSIS 15 0.0030
366 PNEUMOTHORAX 47 0.0030
367 DERMATITIS 62 0.0030
368 CARDIAC DYSFUNCTION 11 0.0030
369 ALTERED STATE OF CONSCIOUSNESS 64 0.0030
370 HYPOMAGNESAEMIA 41 0.0029
371 LUNG INFILTRATION 26 0.0029
372 INTESTINAL PERFORATION 33 0.0029
373 GAIT INABILITY 98 0.0029
374 HEPATITIS ACUTE 19 0.0029
375 HEPATOTOXICITY 65 0.0029
376 FAECAL INCONTINENCE 14 0.0029
377 DISORIENTATION 115 0.0029
378 VIITH NERVE PARALYSIS 10 0.0029
379 ABDOMINAL DISTENSION 302 0.0029
380 PULMONARY MASS 43 0.0029
381 THROMBOTIC MICROANGIOPATHY 28 0.0029
382 BLOOD UREA INCREASED 48 0.0029
383 EJECTION FRACTION DECREASED 44 0.0028
384 FAECES HARD 11 0.0028
385 SHOCK HAEMORRHAGIC 23 0.0028
386 PRURITUS GENERALISED 61 0.0028
387 ABDOMINAL TENDERNESS 14 0.0028
388 COLITIS ISCHAEMIC 19 0.0028
389 ABSCESS LIMB 12 0.0028
390 PULMONARY TUBERCULOSIS 12 0.0028
391 MYELOSUPPRESSION 101 0.0028
392 INCOHERENT 18 0.0028
393 MUSCULOSKELETAL CHEST PAIN 43 0.0028
394 ULCER 44 0.0028
395 HEMIPLEGIA 23 0.0028
396 PATHOLOGICAL FRACTURE 14 0.0028
397 LIVER TRANSPLANT 10 0.0027
398 RASH PUSTULAR 20 0.0027
399 TONGUE DISCOLOURATION 12 0.0027
400 ERYTHEMA 558 0.0027
401 HYPOVOLAEMIC SHOCK 13 0.0027
402 BLOOD CREATININE INCREASED 177 0.0027
403 WOUND HAEMORRHAGE 10 0.0027
404 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
405 TERMINAL STATE 18 0.0027
406 ODYNOPHAGIA 16 0.0027
407 OSTEONECROSIS OF JAW 66 0.0027
408 BLOOD MAGNESIUM DECREASED 23 0.0027
409 ORAL DISCOMFORT 37 0.0027
410 CLOSTRIDIAL INFECTION 9 0.0027
411 CHROMATURIA 60 0.0027
412 GANGRENE 16 0.0027
413 SKIN DISCOLOURATION 122 0.0027
414 EMBOLISM 22 0.0026
415 HAEMATOCHEZIA 145 0.0026
416 ANAL FISTULA 14 0.0026
417 GASTROINTESTINAL MOTILITY DISORDER 14 0.0026
418 HAEMORRHOIDS 51 0.0026
419 LOCALISED OEDEMA 12 0.0026
420 HYPONATRAEMIA 146 0.0026
421 CARDIOPULMONARY FAILURE 10 0.0026
422 BURNING SENSATION 179 0.0026
423 HEPATITIS 65 0.0025
424 HYPERKALAEMIA 89 0.0025
425 FURUNCLE 20 0.0025
426 HOSPITALISATION 386 0.0025
427 ACUTE MYOCARDIAL INFARCTION 74 0.0025
428 SUPRAVENTRICULAR TACHYCARDIA 24 0.0025
429 UPPER GASTROINTESTINAL HAEMORRHAGE 42 0.0025
430 BLOOD DISORDER 20 0.0025
431 ILEUS 31 0.0025
432 FACE OEDEMA 42 0.0025
433 HYPERTHYROIDISM 36 0.0025
434 DRUG ERUPTION 44 0.0025
435 ORGAN FAILURE 10 0.0025
436 CYSTITIS HAEMORRHAGIC 10 0.0025
437 PERITONITIS 51 0.0025
438 BLOOD PRESSURE SYSTOLIC INCREASED 48 0.0025
439 FLANK PAIN 23 0.0025
440 PERIPHERAL ISCHAEMIA 10 0.0024
441 PANCREATITIS ACUTE 55 0.0024
442 ASPERGILLUS INFECTION 16 0.0024
443 COORDINATION ABNORMAL 34 0.0024
444 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
445 SKIN ATROPHY 14 0.0024
446 CEREBRAL HAEMORRHAGE 87 0.0024
447 GASTROINTESTINAL SOUNDS ABNORMAL 12 0.0024
448 OLIGURIA 15 0.0024
449 ABDOMINAL PAIN UPPER 496 0.0024
450 ACUTE GRAFT VERSUS HOST DISEASE 11 0.0024
451 CARDIAC FAILURE ACUTE 16 0.0024
452 CONFUSIONAL STATE 387 0.0024
453 LIMB DISCOMFORT 74 0.0024
454 PLATELET COUNT INCREASED 31 0.0024
455 HYPERPYREXIA 10 0.0024
456 HYPOKALAEMIA 109 0.0024
457 BACTERAEMIA 28 0.0024
458 INTERSTITIAL LUNG DISEASE 114 0.0024
459 STEVENS-JOHNSON SYNDROME 52 0.0023
460 CONSTIPATION 510 0.0023
461 RASH PAPULAR 52 0.0023
462 ANGIOPATHY 13 0.0023
463 BLOOD URINE PRESENT 44 0.0023
464 FATIGUE 1804 0.0023
465 IMPAIRED HEALING 76 0.0023
466 RENAL FAILURE ACUTE 98 0.0023
467 HAEMOGLOBIN DECREASED 236 0.0023
468 APHONIA 32 0.0023
469 OESOPHAGITIS 25 0.0023
470 BLOOD THYROID STIMULATING HORMONE INCREASED 21 0.0023
471 COAGULOPATHY 38 0.0023
472 INTERNAL HAEMORRHAGE 26 0.0023
473 AGEUSIA 56 0.0022
474 BLOOD COUNT ABNORMAL 34 0.0022
475 RESPIRATORY FAILURE 163 0.0022
476 MENTAL STATUS CHANGES 62 0.0022
477 VENOOCCLUSIVE LIVER DISEASE 11 0.0022
478 GINGIVITIS 12 0.0022
479 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
480 DYSURIA 81 0.0022
481 SCAB 25 0.0022
482 ENTERITIS 14 0.0022
483 GASTROINTESTINAL PAIN 24 0.0022
484 BLOOD PRESSURE FLUCTUATION 52 0.0022
485 GASTRITIS 57 0.0022
486 HEPATITIS CHOLESTATIC 13 0.0022
487 BODY TEMPERATURE INCREASED 44 0.0022
488 MUSCULOSKELETAL DISORDER 41 0.0022
489 ACUTE PULMONARY OEDEMA 12 0.0021
490 SPLENOMEGALY 25 0.0021
491 ATRIAL FLUTTER 17 0.0021
492 ACTIVITIES OF DAILY LIVING IMPAIRED 42 0.0021
493 SINUS TACHYCARDIA 30 0.0021
494 SMALL INTESTINAL OBSTRUCTION 26 0.0021
495 MALABSORPTION 11 0.0021
496 RETINAL HAEMORRHAGE 15 0.0021
497 HYPERCALCAEMIA 26 0.0021
498 TROPONIN INCREASED 16 0.0021
499 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
500 VOMITING 984 0.0021
501 DRUG INTOLERANCE 202 0.0021
502 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
503 TONGUE DISORDER 15 0.0021
504 ANORECTAL DISCOMFORT 11 0.0021
505 GAIT DISTURBANCE 395 0.0021
506 SENSITIVE SKIN 15 0.0020
507 PLEURISY 12 0.0020
508 HAEMATURIA 69 0.0020
509 RENAL IMPAIRMENT 169 0.0020
510 TRANSFUSION 21 0.0020
511 BLOOD TEST ABNORMAL 28 0.0020
512 APHASIA 60 0.0020
513 PERITONITIS BACTERIAL 20 0.0020
514 HYPERGLYCAEMIA 72 0.0020
515 THERMAL BURN 14 0.0020
516 ACIDOSIS 15 0.0020
517 CARDIOMYOPATHY 29 0.0020
518 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
519 ADVERSE REACTION 26 0.0020
520 NEUTROPENIC SEPSIS 14 0.0020
521 RASH PRURITIC 106 0.0020
522 OFF LABEL USE 1712 0.0020
523 DECREASED ACTIVITY 21 0.0019
524 RASH ERYTHEMATOUS 93 0.0019
525 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
526 AGRANULOCYTOSIS 36 0.0019
527 VARICOSE VEIN 10 0.0019
528 STOMACH DISCOMFORT 10 0.0019
529 HOSPICE CARE 19 0.0019
530 FLATULENCE 109 0.0019
531 RENAL FAILURE 252 0.0019
532 PULMONARY EMBOLISM 180 0.0019
533 LOCAL SWELLING 33 0.0019
534 SWELLING FACE 123 0.0019
535 HYPERSOMNIA 54 0.0019
536 OEDEMA 102 0.0019
537 HYPOVOLAEMIA 11 0.0019
538 HYPERTRIGLYCERIDAEMIA 11 0.0019
539 BLOOD CREATINE PHOSPHOKINASE INCREASED 54 0.0019
540 BLOOD CALCIUM DECREASED 21 0.0019
541 HAEMATOCRIT DECREASED 37 0.0019
542 HAEMOGLOBIN ABNORMAL 12 0.0019
543 ISCHAEMIC STROKE 33 0.0018
544 DRY MOUTH 150 0.0018
545 CHOLECYSTITIS 22 0.0018
546 HEPATOCELLULAR INJURY 26 0.0018
547 DYSGEUSIA 136 0.0018
548 SPEECH DISORDER 95 0.0018
549 DYSPHAGIA 172 0.0018
550 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
551 APHTHOUS ULCER 14 0.0018
552 NECROSIS 10 0.0018
553 RENAL CANCER 85 0.0018
554 MOBILITY DECREASED 128 0.0018
555 DYSSTASIA 52 0.0018
556 SEPSIS 198 0.0018
557 OROPHARYNGEAL DISCOMFORT 16 0.0018
558 ORAL CANDIDIASIS 23 0.0017
559 SEPTIC SHOCK 76 0.0017
560 ANURIA 15 0.0017
561 BRAIN OEDEMA 22 0.0017
562 FREQUENT BOWEL MOVEMENTS 47 0.0017
563 MUSCULOSKELETAL PAIN 91 0.0017
564 RETCHING 37 0.0017
565 NAUSEA 1369 0.0017
566 SKIN SWELLING 15 0.0017
567 GOUT 31 0.0017
568 METABOLIC DISORDER 10 0.0017
569 POOR QUALITY SLEEP 37 0.0017
570 VASCULITIS 20 0.0017
571 GASTROENTERITIS 25 0.0017
572 COMA 81 0.0017
573 RENAL PAIN 18 0.0017
574 BLOOD POTASSIUM DECREASED 51 0.0017
575 DEATH 1461 0.0017
576 PURPURA 15 0.0017
577 ATRIAL FIBRILLATION 165 0.0017
578 SPINAL COMPRESSION FRACTURE 14 0.0017
579 PNEUMOCYSTIS JIROVECII PNEUMONIA 17 0.0017
580 FISTULA 19 0.0017
581 PERIPHERAL SWELLING 260 0.0017
582 PERICARDIAL EFFUSION 39 0.0017
583 DYSPNOEA EXERTIONAL 63 0.0017
584 SUBARACHNOID HAEMORRHAGE 17 0.0017
585 WHITE BLOOD CELL COUNT INCREASED 64 0.0017
586 WHITE BLOOD CELL COUNT DECREASED 180 0.0017
587 HEPATIC ENZYME INCREASED 113 0.0017
588 EAR DISCOMFORT 17 0.0017
589 LIP DRY 15 0.0016
590 LETHARGY 95 0.0016
591 URINARY RETENTION 55 0.0016
592 ADRENAL INSUFFICIENCY 20 0.0016
593 SKIN MASS 11 0.0016
594 FAECALOMA 9 0.0016
595 LYMPHOCYTE COUNT DECREASED 29 0.0016
596 SWOLLEN TONGUE 51 0.0016
597 LUNG DISORDER 80 0.0016
598 TENDERNESS 17 0.0016
599 FEELING COLD 45 0.0016
600 SHOCK 37 0.0016
601 BLOOD GLUCOSE DECREASED 77 0.0016
602 METABOLIC ACIDOSIS 51 0.0016
603 EAR PAIN 31 0.0016
604 HEMIPARESIS 27 0.0016
605 HYPOXIA 56 0.0016
606 CHOLECYSTITIS ACUTE 9 0.0016
607 PRODUCT USE IN UNAPPROVED INDICATION 393 0.0016
608 RESPIRATORY RATE INCREASED 14 0.0016
609 HEPATITIS C 19 0.0016
610 ARRHYTHMIA 74 0.0016
611 ACUTE RESPIRATORY FAILURE 30 0.0016
612 LEUKOPENIA 78 0.0016
613 ADVERSE DRUG REACTION 140 0.0016
614 MUSCULAR WEAKNESS 177 0.0016
615 COLITIS 59 0.0016
616 PANCREATITIS 82 0.0015
617 CHEST PAIN 287 0.0015
618 DIVERTICULUM 11 0.0015
619 PRURITUS 594 0.0015
620 ANGINA UNSTABLE 10 0.0015
621 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17 0.0015
622 CARDIAC FAILURE 123 0.0015
623 BRAIN NEOPLASM 14 0.0015
624 VISUAL FIELD DEFECT 11 0.0015
625 RECTAL HAEMORRHAGE 65 0.0015
626 DERMATITIS ALLERGIC 19 0.0015
627 LIMB INJURY 41 0.0015
628 PNEUMONITIS 41 0.0015
629 ABDOMINAL PAIN LOWER 38 0.0015
630 PULMONARY OEDEMA 67 0.0015
631 JOINT RANGE OF MOTION DECREASED 20 0.0015
632 SKIN HAEMORRHAGE 22 0.0015
633 DRY THROAT 15 0.0015
634 SUNBURN 11 0.0015
635 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
636 DRUG LEVEL DECREASED 15 0.0015
637 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
638 MOTOR DYSFUNCTION 15 0.0015
639 PRODUCT PRESCRIBING ISSUE 32 0.0015
640 BONE PAIN 86 0.0015
641 HAEMORRHAGE 153 0.0015
642 INFARCTION 10 0.0015
643 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
644 ECCHYMOSIS 10 0.0015
645 APATHY 21 0.0014
646 HYPERTENSIVE CRISIS 16 0.0014
647 HYPERTRANSAMINASAEMIA 10 0.0014
648 TOOTHACHE 26 0.0014
649 DEEP VEIN THROMBOSIS 93 0.0014
650 NEUTROPENIA 194 0.0014
651 LIVER INJURY 35 0.0014
652 INCONTINENCE 15 0.0014
653 PNEUMONIA BACTERIAL 13 0.0014
654 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
655 MITRAL VALVE INCOMPETENCE 16 0.0014
656 GRAND MAL CONVULSION 13 0.0014
657 OROPHARYNGEAL PAIN 130 0.0014
658 RESPIRATORY DISORDER 42 0.0014
659 CHOLELITHIASIS 46 0.0014
660 NASAL DISCOMFORT 11 0.0014
661 PERIPHERAL COLDNESS 19 0.0014
662 DEPRESSED MOOD 73 0.0014
663 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
664 FAECES SOFT 10 0.0014
665 ASPIRATION 15 0.0014
666 PNEUMONIA ASPIRATION 34 0.0014
667 MUSCLE SPASMS 249 0.0014
668 MALAISE 593 0.0014
669 LUNG INFECTION 21 0.0014
670 ASPHYXIA 11 0.0013
671 MUSCLE ATROPHY 17 0.0013
672 PETECHIAE 14 0.0013
673 MYOSITIS 12 0.0013
674 HYDRONEPHROSIS 10 0.0013
675 DIVERTICULITIS 37 0.0013
676 ANAL INCONTINENCE 12 0.0013
677 CONVULSION 76 0.0013
678 OSTEOMYELITIS 24 0.0013
679 WOUND 37 0.0013
680 THERAPY CHANGE 13 0.0013
681 INFLAMMATION 68 0.0013
682 FLUID RETENTION 67 0.0013
683 CELLULITIS 66 0.0013
684 PHARYNGEAL OEDEMA 20 0.0013
685 MADAROSIS 15 0.0013
686 CIRCULATORY COLLAPSE 22 0.0013
687 EXTRASYSTOLES 9 0.0013
688 DIARRHOEA HAEMORRHAGIC 12 0.0013
689 WOUND INFECTION 14 0.0013
690 GASTROINTESTINAL INFLAMMATION 10 0.0013
691 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 61 0.0013
692 DYSPNOEA 715 0.0013
693 DEAFNESS 33 0.0013
694 TRICUSPID VALVE INCOMPETENCE 10 0.0013
695 PARALYSIS 18 0.0013
696 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
697 HYPERLIPIDAEMIA 15 0.0013
698 LABORATORY TEST ABNORMAL 37 0.0013
699 URINARY INCONTINENCE 37 0.0012
700 DRUG TOXICITY 17 0.0012
701 SKIN INFECTION 14 0.0012
702 DRUG RESISTANCE 32 0.0012
703 FOLLICULITIS 13 0.0012
704 PNEUMONIA 397 0.0012
705 NODULE 16 0.0012
706 CYTOPENIA 15 0.0012
707 ANGINA PECTORIS 35 0.0012
708 MYOCARDITIS 14 0.0012
709 ABNORMAL FAECES 10 0.0012
710 DELIRIUM 42 0.0012
711 EYELID OEDEMA 14 0.0012
712 HAEMORRHAGE INTRACRANIAL 18 0.0012
713 RENAL DISORDER 56 0.0012
714 EOSINOPHIL COUNT INCREASED 10 0.0012
715 CHOLESTASIS 23 0.0012
716 URINARY TRACT INFECTION 204 0.0012
717 INCREASED TENDENCY TO BRUISE 11 0.0012
718 GASTRIC DISORDER 41 0.0012
719 BLOOD GLUCOSE FLUCTUATION 13 0.0012
720 CHILLS 139 0.0012
721 APPENDICITIS 11 0.0012
722 NEUTROPHIL COUNT INCREASED 12 0.0012
723 PAIN IN JAW 33 0.0012
724 TEMPERATURE INTOLERANCE 12 0.0012
725 COUGH 325 0.0012
726 LOCALISED INFECTION 28 0.0012
727 THROMBOSIS 93 0.0012
728 VENTRICULAR EXTRASYSTOLES 12 0.0012
729 RED BLOOD CELL COUNT DECREASED 33 0.0012
730 PYELONEPHRITIS 10 0.0012
731 PHOTOSENSITIVITY REACTION 19 0.0011
732 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
733 DYSARTHRIA 43 0.0011
734 DYSPEPSIA 112 0.0011
735 CARDIOMEGALY 14 0.0011
736 COLD SWEAT 20 0.0011
737 THERAPY NON-RESPONDER 51 0.0011
738 PHARYNGITIS 14 0.0011
739 OSTEONECROSIS 37 0.0011
740 TOOTH EXTRACTION 14 0.0011
741 HAIR TEXTURE ABNORMAL 15 0.0011
742 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
743 BACK PAIN 259 0.0011
744 BLOOD PRESSURE DECREASED 74 0.0011
745 PARAESTHESIA 175 0.0011
746 PRODUCTIVE COUGH 53 0.0011
747 MYELODYSPLASTIC SYNDROME 16 0.0011
748 PULMONARY THROMBOSIS 12 0.0011
749 SYNCOPE 110 0.0011
750 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
751 MYOCARDIAL INFARCTION 191 0.0011
752 SKIN IRRITATION 50 0.0011
753 HYPOAESTHESIA 163 0.0011
754 FEELING HOT 66 0.0011
755 CARDIO-RESPIRATORY ARREST 45 0.0011
756 HYPOTENSION 215 0.0011
757 THERAPY CESSATION 55 0.0011
758 LIVER FUNCTION TEST INCREASED 23 0.0011
759 INFECTION 153 0.0011
760 LOSS OF CONSCIOUSNESS 135 0.0011
761 CARDIOGENIC SHOCK 15 0.0010
762 QUALITY OF LIFE DECREASED 14 0.0010
763 TACHYCARDIA 92 0.0010
764 NEUROTOXICITY 18 0.0010
765 THERAPY PARTIAL RESPONDER 16 0.0010
766 NERVOUS SYSTEM DISORDER 32 0.0010
767 NEOPLASM MALIGNANT 68 0.0010
768 RESPIRATORY ARREST 28 0.0010
769 UNEVALUABLE EVENT 76 0.0010
770 ACNE 76 0.0010
771 POLYNEUROPATHY 12 0.0010
772 LEUKOCYTOSIS 18 0.0010
773 DRUG-INDUCED LIVER INJURY 31 0.0010
774 NEURALGIA 24 0.0010
775 NO THERAPEUTIC RESPONSE 12 0.0010
776 ABDOMINAL DISCOMFORT 165 0.0010
777 NEUTROPHIL COUNT DECREASED 40 0.0010
778 HEART RATE IRREGULAR 22 0.0010
779 CYTOMEGALOVIRUS INFECTION 16 0.0010
780 GASTROINTESTINAL DISORDER 86 0.0010
781 ARTERIOSCLEROSIS 9 0.0010
782 PAIN 584 0.0009
783 ANGIOEDEMA 42 0.0009
784 NECK PAIN 53 0.0009
785 CARDIAC ARREST 78 0.0009
786 TASTE DISORDER 19 0.0009
787 POLLAKIURIA 39 0.0009
788 LIP SWELLING 31 0.0009
789 ERUCTATION 18 0.0009
790 HYPOAESTHESIA ORAL 14 0.0009
791 INTESTINAL OBSTRUCTION 35 0.0009
792 CARDIAC FAILURE CONGESTIVE 74 0.0009
793 PALLOR 25 0.0009
794 NEUROPATHY PERIPHERAL 86 0.0009
795 DENTAL CARIES 10 0.0009
796 HEAD DISCOMFORT 16 0.0009
797 UNRESPONSIVE TO STIMULI 23 0.0009
798 CANDIDA INFECTION 15 0.0009
799 HAIR COLOUR CHANGES 11 0.0009
800 CHEST DISCOMFORT 90 0.0009
801 ABSCESS 14 0.0009
802 CARDIAC DISORDER 82 0.0009
803 MYALGIA 149 0.0009
804 DRUG INTERACTION 138 0.0009
805 RESPIRATORY DISTRESS 24 0.0009
806 HEART RATE INCREASED 86 0.0009
807 KIDNEY INFECTION 17 0.0009
808 HEADACHE 541 0.0009
809 CEREBROVASCULAR ACCIDENT 146 0.0009
810 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
811 EOSINOPHILIA 15 0.0009
812 DIPLOPIA 22 0.0008
813 BREAST PAIN 9 0.0008
814 THYROID DISORDER 13 0.0008
815 VISUAL ACUITY REDUCED 28 0.0008
816 BLOOD IRON DECREASED 10 0.0008
817 CONTUSION 81 0.0008
818 SOMNOLENCE 168 0.0008
819 BASAL CELL CARCINOMA 13 0.0008
820 PARAESTHESIA ORAL 12 0.0008
821 AMNESIA 54 0.0008
822 CARDIOVASCULAR DISORDER 21 0.0008
823 TINNITUS 38 0.0008
824 DIZZINESS 409 0.0008
825 DISCOMFORT 50 0.0008
826 EPILEPSY 25 0.0008
827 ACUTE KIDNEY INJURY 125 0.0008
828 SINUS CONGESTION 11 0.0008
829 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
830 ARTHRALGIA 335 0.0008
831 ORTHOSTATIC HYPOTENSION 14 0.0008
832 CORONARY ARTERY OCCLUSION 11 0.0008
833 RESTLESSNESS 29 0.0008
834 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
835 SWELLING 74 0.0008
836 PRODUCT AVAILABILITY ISSUE 18 0.0008
837 MENTAL IMPAIRMENT 19 0.0008
838 HERPES ZOSTER 45 0.0008
839 HAEMATOMA 20 0.0008
840 BONE DISORDER 14 0.0008
841 RHABDOMYOLYSIS 32 0.0008
842 BALANCE DISORDER 66 0.0008
843 CYANOSIS 12 0.0008
844 PRODUCT USE ISSUE 143 0.0008
845 TOOTH INFECTION 10 0.0008
846 STAPHYLOCOCCAL INFECTION 25 0.0008
847 INSOMNIA 201 0.0008
848 BLOOD PRESSURE ABNORMAL 15 0.0008
849 ADVERSE EVENT 69 0.0007
850 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
851 FLUSHING 74 0.0007
852 JOINT STIFFNESS 19 0.0007
853 GASTROOESOPHAGEAL REFLUX DISEASE 58 0.0007
854 FUNGAL INFECTION 24 0.0007
855 FALL 239 0.0007
856 NIGHT SWEATS 23 0.0007
857 JOINT SWELLING 86 0.0007
858 HEART RATE DECREASED 25 0.0007
859 BLINDNESS UNILATERAL 10 0.0007
860 IMPAIRED WORK ABILITY 15 0.0007
861 BRONCHOSPASM 10 0.0007
862 HEPATIC STEATOSIS 13 0.0007
863 CYSTITIS 22 0.0007
864 SENSORY DISTURBANCE 11 0.0007
865 SURGERY 40 0.0007
866 TREMOR 113 0.0007
867 DEMENTIA 19 0.0007
868 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
869 PULMONARY FIBROSIS 13 0.0007
870 EYE HAEMORRHAGE 9 0.0007
871 VERTIGO 41 0.0007
872 VENTRICULAR TACHYCARDIA 11 0.0007
873 TOXICITY TO VARIOUS AGENTS 111 0.0007
874 SKIN BURNING SENSATION 47 0.0007
875 PERICARDITIS 11 0.0007
876 RESPIRATORY TRACT INFECTION 17 0.0007
877 DIALYSIS 9 0.0006
878 RIB FRACTURE 13 0.0006
879 HEAD INJURY 20 0.0006
880 ECZEMA 33 0.0006
881 POST PROCEDURAL COMPLICATION 12 0.0006
882 MOOD ALTERED 17 0.0006
883 URTICARIA 104 0.0006
884 GALLBLADDER DISORDER 11 0.0006
885 CHOKING 12 0.0006
886 DRUG DOSE OMISSION 101 0.0006
887 SKIN CANCER 13 0.0006
888 INFLUENZA LIKE ILLNESS 49 0.0006
889 DIABETES MELLITUS 45 0.0006
890 BACTERIAL INFECTION 11 0.0006
891 BRADYCARDIA 31 0.0006
892 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
893 PRODUCT DOSE OMISSION 38 0.0006
894 PALPITATIONS 68 0.0006
895 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
896 PULMONARY HYPERTENSION 12 0.0006
897 VISION BLURRED 79 0.0006
898 HYPERHIDROSIS 73 0.0006
899 FEELING ABNORMAL 134 0.0006
900 HALLUCINATION 42 0.0006
901 NERVOUSNESS 29 0.0006
902 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
903 GASTROENTERITIS VIRAL 10 0.0006
904 INFLUENZA 61 0.0005
905 NEPHROLITHIASIS 25 0.0005
906 DEPRESSION 124 0.0005
907 MEMORY IMPAIRMENT 73 0.0005
908 BLOOD GLUCOSE INCREASED 99 0.0005
909 PANCREATIC CARCINOMA 15 0.0005
910 OXYGEN SATURATION DECREASED 29 0.0005
911 BLINDNESS 21 0.0005
912 CORONARY ARTERY DISEASE 15 0.0005
913 TREATMENT FAILURE 41 0.0005
914 TOOTH DISORDER 11 0.0005
915 PRESYNCOPE 12 0.0005
916 DRY EYE 24 0.0005
917 THROAT TIGHTNESS 13 0.0005
918 MUSCULOSKELETAL STIFFNESS 42 0.0005
919 BLOOD CHOLESTEROL INCREASED 22 0.0005
920 THROAT IRRITATION 21 0.0005
921 DYSKINESIA 19 0.0005
922 CONDITION AGGRAVATED 142 0.0005
923 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
924 EYE DISORDER 15 0.0005
925 EYE SWELLING 16 0.0004
926 NASOPHARYNGITIS 79 0.0004
927 EAR INFECTION 11 0.0004
928 BRONCHITIS 30 0.0004
929 ABNORMAL BEHAVIOUR 16 0.0004
930 RHINORRHOEA 26 0.0004
931 DISEASE RECURRENCE 19 0.0004
932 SLEEP DISORDER 28 0.0004
933 VISUAL IMPAIRMENT 49 0.0004
934 ERECTILE DYSFUNCTION 10 0.0004
935 LUNG NEOPLASM MALIGNANT 16 0.0004
936 AGITATION 28 0.0004
937 OSTEOARTHRITIS 16 0.0004
938 HYPERSENSITIVITY 70 0.0004
939 DISTURBANCE IN ATTENTION 20 0.0004
940 UNDERDOSE 27 0.0004
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
942 DRUG INEFFECTIVE 478 0.0004
943 ANXIETY 103 0.0004
944 ARTHRITIS 28 0.0004
945 SEIZURE 41 0.0004
946 WHEEZING 21 0.0004
947 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
948 TREATMENT NONCOMPLIANCE 19 0.0003
949 VAGINAL HAEMORRHAGE 15 0.0003
950 PSYCHOTIC DISORDER 10 0.0003
951 VIRAL INFECTION 11 0.0003
952 ANAPHYLACTIC REACTION 18 0.0003
953 MENTAL DISORDER 14 0.0003
954 COGNITIVE DISORDER 15 0.0003
955 EYE PAIN 18 0.0003
956 HOT FLUSH 24 0.0003
957 IRRITABILITY 19 0.0003
958 MOVEMENT DISORDER 10 0.0003
959 LACTIC ACIDOSIS 10 0.0003
960 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
961 WEIGHT INCREASED 67 0.0003
962 EMOTIONAL DISORDER 9 0.0003
963 FEMUR FRACTURE 9 0.0003
964 NASAL CONGESTION 17 0.0003
965 HYPOACUSIS 12 0.0003
966 CRYING 10 0.0003
967 ANGER 9 0.0003
968 CATARACT 15 0.0003
969 SINUSITIS 25 0.0002
970 AGGRESSION 12 0.0002
971 INJURY 16 0.0002
972 CHRONIC KIDNEY DISEASE 17 0.0002
973 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
974 MEDICATION ERROR 12 0.0002
975 ILL-DEFINED DISORDER 13 0.0002
976 ILLNESS 21 0.0002
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
978 THERAPY INTERRUPTED 14 0.0002
979 PSORIASIS 25 0.0002
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
981 THERAPEUTIC RESPONSE DECREASED 11 0.0002
982 INTENTIONAL PRODUCT MISUSE 14 0.0002
983 ASTHMA 18 0.0002
984 SUICIDAL IDEATION 14 0.0002
985 PROSTATE CANCER 11 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
987 MIGRAINE 11 0.0001
988 NO ADVERSE EVENT 20 0.0001
989 COVID-19 19 0.0001
990 INCORRECT DOSE ADMINISTERED 23 0.0001
991 OVERDOSE 19 0.0001
992 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
993 PRODUCT DOSE OMISSION ISSUE 21 0.0001